TCT-584 Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent® SES with Absorbable Polymer
Wijns W, Vrolix M, Verheye S, Schoors D, Slagboom T, Gosselink M, Benit E, Desmet W, Chowdhary S, Lansky A, Bezerra H, Fitzgerald P, Kandzari D, Ormiston J. TCT-584 Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent® SES with Absorbable Polymer. Journal Of The American College Of Cardiology 2012, 60: b169-b170. DOI: 10.1016/j.jacc.2012.08.619.Peer-Reviewed Original ResearchTCT-582 Eighteen Month Clinical and Imaging Results from the DESSOLVE I First-in-Human Trial of the MiStent® SES with Absorbable Polymer
Ormiston J, Stewart J, Webster M, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Bezerra H, Fitzgerald P, Kandzari D, Wijns W. TCT-582 Eighteen Month Clinical and Imaging Results from the DESSOLVE I First-in-Human Trial of the MiStent® SES with Absorbable Polymer. Journal Of The American College Of Cardiology 2012, 60: b169. DOI: 10.1016/j.jacc.2012.08.617.Peer-Reviewed Original Research